The global nucleotides market size reached US$ 667.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 995.3 Million by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.
Nucleotides are the basic building block of nucleic acids, such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). They enhance various metabolic processes and the formation of the structure of proteins synthesized in the cell. They act with enzymes to speed up biochemical reactions in the body. They also aid in the biosynthesis of macromolecules and cell signaling through interaction with purinergic receptors. In addition, nucleotides assist in encoding, transmitting, and expressing genetic information in the body. As they provide a high degree of potency and selectivity against the herpes group of viruses, nucleotides are used as antiviral or anticancer agents in several medicines.
Nucleotides Market Trends:
At present, there is a rise in the utilization of nucleotide supplements in dairy products, such as yogurt and condensed and powdered milk, across the globe. This, along with the growing availability of these supplements in the form of powdered fluids, represents one of the key factors driving the market. Besides this, the increasing employment of nucleotides in nutraceuticals to treat conditions, such as poor nutrition, stress, and hypertension, is contributing to the growth of the market. In addition, the rising application of nucleotides in diagnostic research to diagnose the presence of various viral diseases and types of cancer is propelling the growth of the market. Moreover, there is an increase in the demand for nucleotides in animal feed to maintain metabolism rates in livestock. This, coupled with the growing awareness among the masses about the harmful impacts of animal diseases, is positively influencing the market. Apart from this, the escalating demand for nucleotides to enhance the recovery of intestinal epithelial cells, which helps boost the immunity system, is offering a positive market outlook. Additionally, the increasing usage of ribonucleotides in infant food formulations is bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleotides market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, form and application.
Breakup by Type:
- Food Grade
- Lab Grade
- Industry Grade
Breakup by Technology:
- TaqMan Allelic Discrimination
- Gene Chips and Microarrays
- SNP by Pyrosequencing
Breakup by Form:
Breakup by Application:
- Food and Animal Feed Additives
- Drug Discovery
Breakup by Region:
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
| Historical Period
||Type, Technology, Form, Application, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global nucleotides market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global nucleotides market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the form?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global nucleotides market and who are the key players?
- What is the degree of competition in the industry?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the nucleotides market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global nucleotides market.
- The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the nucleotides industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.